DepoMed, Inc. (NASDAQ:DEPO)

CAPS Rating: 4 out of 5

A specialty pharmaceutical company focused on the development and commercialization of differentiated products that address growing markets and are based on proprietary oral drug delivery technologies.

Recs

0
Player Avatar gravmic (< 20) Submitted: 5/16/2011 3:25:49 PM : Underperform Start Price: $8.04 DEPO Score: +30.71

magic formula

Featured Broker Partners


Advertisement